Searched for
NESHER PHARMACEUTICALS
Top stocks in focus on Monday, 18 September 2017Here is a list of top stocks that are likely to be in focus in today's trading session.- Zydus' Nesher Pharma gets USFDA nod to market influenza drugZydus' Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir powder for oral suspension, 6 mg/ml, said th...
- Top stocks in focus on Monday, 12 June 2017Weak signals from global markets and some key data releases may chart market direction.
- Zydus subsidiary receives USFDA nod to market Tamiflu drugThe group now has more than 110 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in 2003-04 fiscal
- Zydus group firm Nesher Pharmaceuticals gets USFDA nod for a drug"The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher," it added.
- Zydus gets USFDA nod for morphine sulfate tabletsZydus Group today announced receipt of approval to sell chronic pain reliever morphine sulfate tablets from the US Food and Drug Administra...
- Cadila Healthcare PAT seen down 16% at Rs 192crNet sales are expected to have grown 4 per cent to Rs 1,466 crore in the first quarter from Rs 1,173 crore in the year-ago period. Earnings...
- Cadila Healthcare Q3 net dips by 4.4%, sales rise 20%Cadila Healthcare, the flagship company of Zydus group, has suffered a 4.4% drop in its third quarter net profit on account of forex losses.
- Zydus Cadila buys out Biochem PharmaceuticalsZydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.
- Zydus Cadila in talks to acquire brands and manufacturing facility of Biochem PharmaceuticalsThe deal is expected to be valued at Rs 300-450 cr and will boost Biochem's revenue growth. In fiscal 2009-10, Biochem reported revenues of...
- Zydus Cadila Q1 net up 15.38% at Rs 229.82 croreAhmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...
- Zydus plans to buy US drug cos for $60 mnZydus Cadila plans to acquire US-based generic pharma company. The Ahmedabad-based firm signed an asset purchase agreement with a US-based ...
Load More
